ADVANCED BIOMED INC (ADVB) Stock Price, Forecast & Analysis

USA • Nasdaq • NASDAQ:ADVB • US00752P1049

0.2319 USD
-0.01 (-2.97%)
At close: Feb 6, 2026
0.2319 USD
0 (0%)
After Hours: 2/6/2026, 8:16:56 PM

ADVB Key Statistics, Chart & Performance

Key Statistics
Market Cap5.02M
Revenue(TTM)N/A
Net Income(TTM)-3.38M
Shares21.64M
Float4.86M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.16
PEN/A
Fwd PEN/A
Earnings (Next)04-13
IPO2025-03-06
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
ADVB short term performance overview.The bars show the price performance of ADVB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

ADVB long term performance overview.The bars show the price performance of ADVB in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of ADVB is 0.2319 USD. In the past month the price decreased by -34.58%.

ADVANCED BIOMED INC / ADVB Daily stock chart

ADVB Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ADVB Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ADVB. The financial health of ADVB is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ADVB Financial Highlights

Over the last trailing twelve months ADVB reported a non-GAAP Earnings per Share(EPS) of -0.16. The EPS decreased by -23.48% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -54.15%
ROE -112.52%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-45.53%
Sales Q2Q%N/A
EPS 1Y (TTM)-23.48%
Revenue 1Y (TTM)N/A

ADVB Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

ADVB Ownership

Ownership
Inst Owners1.21%
Ins Owners67.44%
Short Float %4.97%
Short Ratio0.37

ADVB Latest News, Press Relases and Analysis

ADVB Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
COO COOPER COS INC/THE1816.322B
SOLV SOLVENTUM CORP12.0713.55B
ALGN ALIGN TECHNOLOGY INC16.7513.46B
MMSI MERIT MEDICAL SYSTEMS INC19.994.891B
LNTH LANTHEUS HOLDINGS INC11.484.303B
ICUI ICU MEDICAL INC18.793.806B
HAE HAEMONETICS CORP/MASS10.812.778B
XRAY DENTSPLY SIRONA INC8.842.746B
NEOG NEOGEN CORP31.842.347B
UFPT UFP TECHNOLOGIES INC26.672.061B

About ADVB

Company Profile

ADVB logo image Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. The company is headquartered in Reno, Nevada and currently employs 31 full-time employees. The company went IPO on 2025-03-06. The firm is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, and treatment of cancer through the detection of circulating tumor cells and related tumor markers. The company has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The firm offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.

Company Info

ADVANCED BIOMED INC

401 Ryland St, Ste 200-A

Reno NEVADA US

Employees: 31

ADVB Company Website

ADVB Investor Relations

Phone: 1862120510823

ADVANCED BIOMED INC / ADVB FAQ

Can you describe the business of ADVANCED BIOMED INC?

Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. The company is headquartered in Reno, Nevada and currently employs 31 full-time employees. The company went IPO on 2025-03-06. The firm is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, and treatment of cancer through the detection of circulating tumor cells and related tumor markers. The company has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The firm offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.


What is the current price of ADVB stock?

The current stock price of ADVB is 0.2319 USD. The price decreased by -2.97% in the last trading session.


What is the dividend status of ADVANCED BIOMED INC?

ADVB does not pay a dividend.


How is the ChartMill rating for ADVANCED BIOMED INC?

ADVB has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


On which exchange is ADVB stock listed?

ADVB stock is listed on the Nasdaq exchange.


What is the GICS sector and industry of ADVB stock?

ADVANCED BIOMED INC (ADVB) operates in the Health Care sector and the Health Care Equipment & Supplies industry.